Argenica Therapeutics LtdASX: AGN

Appendix 4G & Corporate Governance Statement

· Issued by Argenica Therapeutics Ltd via ASX

Filed with ASX ·

Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity ARGENICA THERAPEUTICS LIMITED ABN/ARBN Financial year ended: 78 637 578 753 30 JUNE 2026 ...

View Attachment

6ix hasn’t read this filing yet.

Argenica Therapeutics Ltd on 6ix

Earlier from Argenica Therapeutics

Later from Argenica Therapeutics

All Argenica Therapeutics news releases